3. Summary of quality of life assessments made in included studies.
| Study | QOL instrument | notes |
| Dietary advice versus no advice ‐ group 1 | ||
| Alo 2014 | ||
| Baldwin 2011 | EORTC FAACT |
Mean change from baseline to 6 and 26 weeks |
| Campbell 2008 | KDQOL‐SF | Data provided by author on mean (SD) at baseline and 12 weeks for each component |
| Cano‐Torres 2017 | ||
| Casals 2015 | SF‐12 | Mean change from baseline to 6 months |
| Dixon 1984 | ||
| Fernandez‐Barres 2017 | ||
| Forster 2012 | SF‐36 | Mean change from baseline to 3 months obtained from author |
| Gu 2015 | ||
| Imes 1988 | ||
| Kunvik 2018 | ||
| Locher 2013 | ||
| Macia 1991 | ||
| Manguso 2005 | ||
| Ollenschlager 1992 | Subjective well‐being using Linear Analogue Self Assessment questionnaire (LASA) |
assessed in intervention group only |
| Pivi 2011 | ||
| Ravasco 2005a | EORTC | Mean change from baseline to 12 weeks plus additional data for longer term follow‐up provided in 2012 publication |
| Ravasco 2005b | EORTC | Mean change from baseline to 12 weeks plus additional data for longer term follow‐up provided in 2012 publication |
| Rydwik 2008 | ||
| Salva 2011 | ||
| Stow 2015 | EQ5D‐5: Dartmouth COOP Quality of life chart |
not reported because of completion by too few residents |
| Tu 2013 | ||
| Weekes 2009 | SF‐36 SGRQ |
Mean change from baseline to 6 and 12 months |
| Wong 2004 | ||
| Dietary advice versus supplements ‐ group 2 | ||
| Akpele 2004 | ||
| Baldwin 2011 | EORTC FAACT |
Mean change from baseline to 6 and 26 weeks |
| Gray‐Donald 1995 | General self‐perceived health question General well‐being schedule |
Mean scores for both groups at baseline and 12 weeks |
| Hernandez 2014 | ||
| Kalnins 2005 | ||
| Parsons 2016 | EuroQol/EQ‐5d | scores reported as baseline scores for both intervention groups combined and mean (SE) after 6 weeks and 12 weeks by intervention group. |
| Pivi 2011 | ||
| Ravasco 2005a (C/R) | EORTC | Mean change from baseline to 12 weeks plus additional data for longer term follow‐up provided in 2012 publication |
| Ravasco 2005b (H/N) | EORTC | Mean change from baseline to 12 weeks plus additional data for longer term follow‐up provided in 2012 publication |
| Schwenk 1999 | ||
| Singh 2008 | ||
| Stow 2015 | EQ5D‐5: Dartmouth COOP Quality of life chart |
not reported because of completion by too few residents |
| Dietary advice versus dietary advice and supplements ‐ group 3 | ||
| Arnold 1989 | ||
| Baldwin 2011 | EORTC FAACT |
Mean change from baseline to 6 and 26 weeks |
| Beattie 2000 | SF‐36 | Summary and mean change scores for physical and mental health at baseline and final assessment |
| Burden 2011 | ||
| Burden 2017 | ||
| de Luis 2003 | ||
| de Sousa 2012 | ||
| Diouf 2016 | ||
| Dixon 1984 | ||
| Fuenzalida 1990 | ||
| Gonzalez‐Espinoza 2005 | ||
| Huynh 2015 | ||
| Kapoor 2017 | EORTC‐C30 | mean change from baseline to 3 months and 6 months |
| Kendell 1982 | ||
| Le Cornu 2000 | ||
| McCarthy 1999 | ||
| Murphy 1992 | ||
| Norman 2008b | SF‐36 | Mean scores for QALYs for all domains at baseline and 3 months |
| Olejko 1984 | ||
| Rabeneck 1998 | 30‐item QOL instrument (not validated) | |
| Sharma 2002a | ||
| Swaminathan 2010 | ||
| Wilson 2001 | ||
| Dietary advice plus supplements if required versus no advice ‐ group 4 | ||
| Andersson 2017 | EQ‐5D | Mean change from baseline to 3 months in all 5 domains |
| Banks 2016 | ||
| Beck 2012 | ||
| Beck 2015 | EQ‐5D | Mean change from baseline to 3 months |
| Bonilla‐Palomas 2016 | ||
| Bourdel‐Marchasson 2014 | ||
| Caccialanza 2015 | SF‐36 | Mean change from baseline to 12 months for PCS and MCS |
| Carey 2013 | EORTC‐QLQ‐C30 | Mean change from baseline to 3 months and 6 months |
| Endevelt 2011 | ||
| Evans 1987 | ||
| Feldblum 2011 | ||
| Forli 2001 | ||
| Ganzoni 1994; | ||
| Hampson 2003 | ||
| Holyday 2012 | ||
| Isenring 2004 | EORTC QLQ‐C30 | Mean change from baseline to 12 weeks |
| Jensen 1997 | QOL index | Means values at baseline and 4 months |
| Kiss 2016 | FACT‐L | From baseline to 3 months following completion of radiation therapy |
| Lovik 1996 | ||
| Moloney 1983 | ||
| Ovesen 1993 | QOL index (modified) | Mean scores at baseline and 3 and 5 months |
| Pedersen 2016a; Pedersen 2016b | SF‐36 | Mean change of subscores from baseline to eight weeks |
| Persson 2002 | EORTC | Mean scores at baseline and 24 months |
| Rogers 1992 | Sickness Impact Profile | Change after 4 months |
| Schilp 2013 | EQ‐5D | Results reported as QALY |
| Sharma 2002a | EQ‐5D | Mean change from baseline to 3 months |
| Silvers 2014 | EORTC‐QLQ‐C30 and EQ‐5D | Mean change from baseline to 6 months |
| Starke 2011 | ||
| Suominen 2015 | HRQoL | Mean change from baseline to 12 months |
| Terp 2018 | ||
| Uster 2013 | EORTC‐C30 | Mean change from baseline to 3 and 6 months |
| Vivanti 2015 | EQ‐5D | Mean change from baseline to 12 weeks |
| Dietary advice plus supplements versus no advice and no supplements ‐ group 5 | ||
| Anbar 2014 | Not reported | |
| Baldwin 2011 | EORTC FAACT |
Mean change from baseline to 6 and 26 weeks |
| Berneis 2000 | Medical Outcomes Study Instrument (adapted for use in patients with HIV infection) | Summary scores (physical function, social role, mental health and pain) at baseline and 12 weeks. Scores range from 1 to 6 with 6 being the optimal score. |
| Calegari 2011 | SF‐36 | Baseline and end of Phase 1 (3 months) scores for all eight domains (physical role functioning, bodily pain, physical functioning, general health, vitality, social functioning, role emotional and mental health). |
| Chandra 1985 | Not reported | |
| Hampson 2003 | Not reported | |
| Jahnavi 2010 | 36‐item Medical Outcomes Study Short form (adapted for use in patients with HIV infection) i.e. SF‐36 (modified) | Baseline scores and mean changes at 3 months for all eight domains (physical role functioning, bodily pain, physical functioning, general health, vitality, social functioning, role emotional and mental health) |
| Neelemaat 2011 | SF‐12 and 3‐level EuroQol‐5D (EQ‐5D) | EQ‐5D was used in the cost effectiveness analysis; QALYs at baseline and difference between groups at 3 months |
| Paton 2004 | 30‐item Medical Outcomes Study Short form (adapted for use in patients with HIV infection) i.e. SF‐36 (modified) | Baseline scores and mean changes at 6, 12 and 24 weeks for all domains |
| Payette 2002 | 36‐item SF‐36 | Scores at baseline and 16 weeks for three domains (physical role functioning, emotional role functioning and vitality) |
| Persson 2007 | SF‐36 | Summary scores at baseline and 4 months for physical and mental domains.Graphical presentation of changes in all domain scores over time. |
| Um 2014 | 30‐item EORTC | Scores at baseline, end of radiotherapy and 1 month follow‐up for function and symptom scales plus global health status |
| Wyers 2013 | 3‐level EQ‐5D | Used in the cost effectiveness analysis; intervention effect for change in QALYs |
EORTC: European organisation for research and treatment of cancer FAACT: functional assessment anorexia‐cancer therapy KDQOL‐SF: Kidney Disease Quality of Life Short Form QOL: quality of life SF‐36: 36‐item Short Form Medical Outcomes Study Instrument SGRQ: St George respiratory questionnaire